Posts Tagged ‘Schedule III Controlled Substance’

The drug xylazine – or ‘Tranq’ has been added as a Schedule III controlled substance in Delaware. ‘Tranq’ is a non-opioid drug used primarily in veterinary medicine, but has been used increasingly as an additive in opioid abuse to create a ‘zombie-like’ condition for users. This action by Delaware Secretary of State Jeff Bullock follows…